• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过与底物结合的CYP102晶体结构同源性对人CYP2B同工型CYP2B6进行分子建模:评估CYP2B6底物特征、细胞色素b5结合位点并与CYP2B1和CYP2B4进行比较。

Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.

作者信息

Lewis D F, Lake B G, Dickins M, Eddershaw P J, Tarbit M H, Goldfarb P S

机构信息

Molecular Toxicology Group, School of Biological Sciences, University of Surrey, Guildford, UK.

出版信息

Xenobiotica. 1999 Apr;29(4):361-93. doi: 10.1080/004982599238560.

DOI:10.1080/004982599238560
PMID:10375007
Abstract
  1. Molecular modelling studies of CYP2B isoforms from rat (CYP2B1), rabbit (CYP2B4) and man (CYP2B6) are reported, with particular emphasis on substrate interactions with the human CYP2B isoform, CYP2B6. 2. The findings represent an advance on our previous study that focused primarily on the rat CYP2B isoform, CYP2B1, and involved homology modelling with substrate-free CYP102. 3. The current work utilizes the recently published substrate-bound CYP102 crystal structure as a template for construction of the CYP2B subfamily isoforms and shows, in particular, that known CYP2B6 substrate specificity and regioselectivity can be rationalized by putative active site interactions.
摘要
  1. 报道了大鼠(CYP2B1)、兔(CYP2B4)和人(CYP2B6)CYP2B同工型的分子模拟研究,特别强调了底物与人CYP2B同工型CYP2B6的相互作用。2. 这些发现是我们之前研究的进展,之前的研究主要集中在大鼠CYP2B同工型CYP2B1上,并涉及与无底物CYP102的同源建模。3. 目前的工作利用最近发表的与底物结合的CYP102晶体结构作为构建CYP2B亚家族同工型的模板,尤其表明已知的CYP2B6底物特异性和区域选择性可以通过假定的活性位点相互作用得到合理解释。

相似文献

1
Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.通过与底物结合的CYP102晶体结构同源性对人CYP2B同工型CYP2B6进行分子建模:评估CYP2B6底物特征、细胞色素b5结合位点并与CYP2B1和CYP2B4进行比较。
Xenobiotica. 1999 Apr;29(4):361-93. doi: 10.1080/004982599238560.
2
Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactions.基于与CYP2C5晶体结构的同源性对CYP2B6进行分子建模:酶-底物相互作用分析。
Drug Metabol Drug Interact. 2002;19(2):115-35. doi: 10.1515/dmdi.2002.19.2.115.
3
Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure.基于CYP2C5晶体结构的人类CYP2家族酶的同源建模。
Xenobiotica. 2002 Apr;32(4):305-23. doi: 10.1080/00498250110112015.
4
Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.使用苯氧苯胺类似物深入了解多溴二苯醚与CYP2B酶相互作用的生化机制。
Biochemistry. 2018 Feb 6;57(5):817-826. doi: 10.1021/acs.biochem.7b01024. Epub 2017 Dec 19.
5
Molecular modelling of CYP4A subfamily members based on sequence homology with CYP102.基于与CYP102的序列同源性对CYP4A亚家族成员进行分子建模。
Xenobiotica. 1999 Aug;29(8):763-81. doi: 10.1080/004982599238227.
6
Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners.
Xenobiotica. 1997 May;27(5):443-78. doi: 10.1080/004982597240433.
7
Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform.通过与CYP102血红蛋白结构域同源性进行人CYP2E1的分子建模:对人CYP2E1同工酶假定活性位点内底物和抑制剂相互作用的研究。
Xenobiotica. 2000 Jan;30(1):1-25. doi: 10.1080/004982500237794.
8
Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences.CYP2B 酶抑制剂和底物的定量构效关系(QSARs):化合物脂溶性在解释效价差异中的重要性。
J Enzyme Inhib Med Chem. 2010 Oct;25(5):679-84. doi: 10.3109/14756360903514149.
9
Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles.苯并咪唑对CYP2B4、CYP2B5和CYP2B1的差异抑制作用至关重要的氨基酸残基。
Mol Pharmacol. 2001 Mar;59(3):475-84. doi: 10.1124/mol.59.3.475.
10
Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.基于与CYP102的序列同源性对CYP1家族酶CYP1A1、CYP1A2、CYP1A6和CYP1B1进行分子建模。
Toxicology. 1999 Nov 29;139(1-2):53-79. doi: 10.1016/s0300-483x(99)00098-0.

引用本文的文献

1
Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry.依非韦伦代谢:多态 CYP2B6 变体和立体化学的影响。
Drug Metab Dispos. 2019 Oct;47(10):1195-1205. doi: 10.1124/dmd.119.086348. Epub 2019 Jul 19.
2
Halogen Substitution Influences Ketamine Metabolism by Cytochrome P450 2B6: In Vitro and Computational Approaches.卤素取代基通过细胞色素 P450 2B6 影响氯胺酮代谢:体外和计算方法。
Mol Pharm. 2019 Feb 4;16(2):898-906. doi: 10.1021/acs.molpharmaceut.8b01214. Epub 2019 Jan 10.
3
Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance.
细胞色素 P450 2B6(CYP2B6)的遗传药理学:多态性、机制和临床相关性的进展。
Front Genet. 2013 Mar 5;4:24. doi: 10.3389/fgene.2013.00024. eCollection 2013.
4
Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.细胞色素P450系统中的定量构效关系(QSARs):描述P450底物结合、抑制和诱导的QSARs。
Inflammopharmacology. 2003;11(1):43-73. doi: 10.1163/156856003321547112.
5
Explicit water near the catalytic I helix Thr in the predicted solution structure of CYP2A4.细胞色素P450 2A4预测溶液结构中靠近催化性I螺旋苏氨酸处的显性水。
Biophys J. 2003 Jan;84(1):57-68. doi: 10.1016/S0006-3495(03)74832-2.